Ion Mobility Mass Spectrometry Measures the Conformational Landscape of p27 and its Domains and how this is Modulated upon Interaction with Cdk2/cyclin A

Angew Chem Int Ed Engl. 2019 Mar 4;58(10):3114-3118. doi: 10.1002/anie.201812697. Epub 2019 Jan 24.

Abstract

Intrinsically disordered proteins have been reported to undergo disorder-to-order transitions upon binding to their partners in the cell. The extent of the ordering upon binding and the lack of order prior to binding is difficult to visualize with classical structure determination methods. Binding of p27 to the Cdk2/cyclin A complex is accompanied by partial folding of p27 in the KID domain, with the retention of dynamic behavior for function, particularly in the C-terminal half of the protein. Herein, native ion mobility mass spectrometry (IM-MS) is employed to measure the intrinsic dynamic properties of p27, both in isolation and within the trimeric complex with Cdk2/cyclin A. The trimeric Cdk2/cyclin A/p27-KID complex possesses significant structural heterogeneity compared to Cdk2/cyclin A. These findings support the formation of a fuzzy complex in which both the N- and C-termini of p27 interact with Cdk2/cyclin A in multiple, closely associated states.

Keywords: intrinsically disordered proteins; ion mobility mass spectrometry; protein structure.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cyclin A / chemistry
  • Cyclin A / metabolism*
  • Cyclin-Dependent Kinase 2 / chemistry
  • Cyclin-Dependent Kinase 2 / metabolism*
  • Cyclin-Dependent Kinase Inhibitor p27 / chemistry
  • Cyclin-Dependent Kinase Inhibitor p27 / metabolism*
  • Humans
  • Intrinsically Disordered Proteins / metabolism
  • Ion Mobility Spectrometry
  • Mass Spectrometry
  • Protein Binding
  • Protein Conformation
  • Protein Folding
  • Protein Interaction Domains and Motifs
  • Protein Interaction Maps
  • Protein Multimerization

Substances

  • Cyclin A
  • Intrinsically Disordered Proteins
  • Cyclin-Dependent Kinase Inhibitor p27
  • CDK2 protein, human
  • Cyclin-Dependent Kinase 2